127 related articles for article (PubMed ID: 19553242)
21. Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux.
Wang N; Tall AR
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1178-84. PubMed ID: 12738681
[TBL] [Abstract][Full Text] [Related]
22. Accumulation of cardiolipin and lysocardiolipin in fibroblasts from Tangier disease subjects.
Fobker M; Voss R; Reinecke H; Crone C; Assmann G; Walter M
FEBS Lett; 2001 Jul; 500(3):157-62. PubMed ID: 11445077
[TBL] [Abstract][Full Text] [Related]
23. POPC/apoA-I discs as a potent lipoprotein modulator in Tangier disease.
Uehara Y; Tsuboi Y; Zhang B; Miura S; Baba Y; Higuchi MA; Yamada T; Rye KA; Saku K
Atherosclerosis; 2008 Mar; 197(1):283-9. PubMed ID: 17560579
[TBL] [Abstract][Full Text] [Related]
24. A complex phenotype in a child with familial HDL deficiency due to a novel frameshift mutation in APOA1 gene (apoA-IGuastalla).
Pisciotta L; Vitali C; Favari E; Fossa P; Adorni MP; Leone D; Artom N; Fresa R; Calabresi L; Calandra S; Bertolini S
J Clin Lipidol; 2015; 9(6):837-846. PubMed ID: 26687706
[TBL] [Abstract][Full Text] [Related]
25. Tangier disease: epidemiology, pathophysiology, and management.
Puntoni M; Sbrana F; Bigazzi F; Sampietro T
Am J Cardiovasc Drugs; 2012 Oct; 12(5):303-11. PubMed ID: 22913675
[TBL] [Abstract][Full Text] [Related]
26. Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia.
Slatter TL; Williams MJ; Frikke-Schmidt R; Tybjaerg-Hansen A; Morison IM; McCormick SP
Atherosclerosis; 2006 Aug; 187(2):393-400. PubMed ID: 16225879
[TBL] [Abstract][Full Text] [Related]
27. Serum amyloid A promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells.
Stonik JA; Remaley AT; Demosky SJ; Neufeld EB; Bocharov A; Brewer HB
Biochem Biophys Res Commun; 2004 Sep; 321(4):936-41. PubMed ID: 15358117
[TBL] [Abstract][Full Text] [Related]
28. [The role of transmembrane lipidtransporter molecules in the atherosclerotic process].
Harangi M; Köbling T; Paragh G
Orv Hetil; 2006 Feb; 147(6):251-7. PubMed ID: 16610615
[TBL] [Abstract][Full Text] [Related]
29. A case of Tangier disease with a novel mutation in the C-terminal region of ATP-binding cassette transporter A1.
Guan JZ; Tamasawa N; Brunham LR; Matsui J; Murakami H; Suda T; Ochiai S; Tsutsui M; Kudou K; Satoh K; Hayden MR
Am J Med Genet A; 2004 Nov; 130A(4):398-401. PubMed ID: 15384103
[TBL] [Abstract][Full Text] [Related]
30. Genetic etiology of isolated low HDL syndrome: incidence and heterogeneity of efflux defects.
Kiss RS; Kavaslar N; Okuhira K; Freeman MW; Walter S; Milne RW; McPherson R; Marcel YL
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1139-45. PubMed ID: 17303779
[TBL] [Abstract][Full Text] [Related]
31. Genotypic variation in ATP-binding cassette transporter-1 (ABCA1) as contributors to the high and low high-density lipoprotein-cholesterol (HDL-C) phenotype.
Mantaring M; Rhyne J; Ho Hong S; Miller M
Transl Res; 2007 Apr; 149(4):205-10. PubMed ID: 17383594
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol.
Candini C; Schimmel AW; Peter J; Bochem AE; Holleboom AG; Vergeer M; Dullaart RP; Dallinga-Thie GM; Hovingh GK; Khoo KL; Fasano T; Bocchi L; Calandra S; Kuivenhoven JA; Motazacker MM
Atherosclerosis; 2010 Dec; 213(2):492-8. PubMed ID: 20880529
[TBL] [Abstract][Full Text] [Related]
33. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency.
Brooks-Wilson A; Marcil M; Clee SM; Zhang LH; Roomp K; van Dam M; Yu L; Brewer C; Collins JA; Molhuizen HO; Loubser O; Ouelette BF; Fichter K; Ashbourne-Excoffon KJ; Sensen CW; Scherer S; Mott S; Denis M; Martindale D; Frohlich J; Morgan K; Koop B; Pimstone S; Kastelein JJ; Genest J; Hayden MR
Nat Genet; 1999 Aug; 22(4):336-45. PubMed ID: 10431236
[TBL] [Abstract][Full Text] [Related]
34. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study.
van Dam MJ; de Groot E; Clee SM; Hovingh GK; Roelants R; Brooks-Wilson A; Zwinderman AH; Smit AJ; Smelt AH; Groen AK; Hayden MR; Kastelein JJ
Lancet; 2002 Jan; 359(9300):37-42. PubMed ID: 11809185
[TBL] [Abstract][Full Text] [Related]
35. Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders.
Pisciotta L; Hamilton-Craig I; Tarugi P; Bellocchio A; Fasano T; Alessandrini P; Bon GB; Siepi D; Mannarino E; Cattin L; Averna M; Cefalù AB; Cantafora A; Calandra S; Bertolini S
Atherosclerosis; 2004 Feb; 172(2):309-20. PubMed ID: 15019541
[TBL] [Abstract][Full Text] [Related]
36. Reduced platelet count, but no major platelet function abnormalities, are associated with loss-of-function ATP-binding cassette-1 gene mutations.
Minuz P; Meneguzzi A; Femia EA; Fava C; Calabria S; Scavone M; Benati D; Poli G; Zancanaro C; Calandra S; Lucchi T; Cattaneo M
Clin Sci (Lond); 2017 Aug; 131(16):2095-2107. PubMed ID: 28634189
[TBL] [Abstract][Full Text] [Related]
37. ABCA1-dependent mobilization of lysosomal cholesterol requires functional Niemann-Pick C2 but not Niemann-Pick C1 protein.
Boadu E; Nelson RC; Francis GA
Biochim Biophys Acta; 2012 Mar; 1821(3):396-404. PubMed ID: 22179027
[TBL] [Abstract][Full Text] [Related]
38. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
[TBL] [Abstract][Full Text] [Related]
39. The ATP-binding cassette transporter A1 R230C variant affects HDL cholesterol levels and BMI in the Mexican population: association with obesity and obesity-related comorbidities.
Villarreal-Molina MT; Aguilar-Salinas CA; Rodríguez-Cruz M; Riaño D; Villalobos-Comparan M; Coral-Vazquez R; Menjivar M; Yescas-Gomez P; Königsoerg-Fainstein M; Romero-Hidalgo S; Tusie-Luna MT; Canizales-Quinteros S;
Diabetes; 2007 Jul; 56(7):1881-7. PubMed ID: 17287470
[TBL] [Abstract][Full Text] [Related]
40. Plasma amyloid-β in patients with Tangier disease.
Shahim P; Bochem AE; Mattsson N; Lautner R; Blennow K; Hovingh GK; Motazacker MM; Zetterberg H
J Alzheimers Dis; 2013; 35(2):307-12. PubMed ID: 23388172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
